Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ LAA Exclusion System in subjects undergoing concomitant cardiac surgery.


Clinical Trial Description

Multi center, single-arm, nonrandomized, interventional, unblinded, post-market study. Up to 150 subjects will be enrolled and implanted with the Penditure™ LAA Exclusion Clip at up to 25 sites in the United States. Subjects will be followed at 30 days, 3 months, 12-months and annually for 36-months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06203054
Study type Interventional
Source Medtronic Cardiac Surgery
Contact Morgan Judkins
Phone +17635149752
Email morgan.l.judkins@medtronic.com
Status Recruiting
Phase N/A
Start date February 26, 2024
Completion date February 2029

See also
  Status Clinical Trial Phase
Completed NCT00779857 - AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery Phase 2